Professor Ching-Hong Yang and his research team have secured a $1 million dollar grant from the USDA Organic Transit program, advancing the innovative project titled “Revolutionizing Organic Fire Blight Management: Harnessing the Power of Novel Biocontrol Bacterium Pseudomonas soli T307.”… Read More
The project, titled “Evaluate the Effectiveness of RAA, a Natural Metabolite, in Controlling HLB through Foliar Spray and a Combination of RAA with Oxytetracycline via Trunk Injection,” has been awarded a substantial $1.4 million from the USDA, ECDRE program to… Read More
Current cancer drugs most often do not distinguish between malignant cells and healthy cells thus leading to the many side effects seen during cancer chemotherapy. Dr. Peng’s group has designed patented cancer pro-drugs which are selectively activated by conditions that… Read More
Cancer cells are in a state of increased basal oxidative stress due to their aberrant growth. As a result, cancer cells have elevated levels of reactive oxygen species (ROS) compared to normal cells. This feature has been employed to develop… Read More
Memory impairment is a defining characteristic of many neuropsychiatric disorders, however, an understanding of the complex neural mechanisms regulating hippocampal memory formation remains elusive. To investigate this neural mechanism, the National Institute of Neurological Disorders and Stroke has awarded several… Read More
We are delighted to announce Professor Qingsu Cheng has newest MIDD member. Dr. Cheng has previously worked as postdoctoral researcher at Lawrence Berkeley National Laboratory and Research Scientist at the University of Nevada in Reno. Dr. Cheng’s research focuses on… Read More
We are very proud of our MIDD members that support the ACS SEED (Summer Experience for the Economically Disadvantaged) this year. The ACS project enrolls more than 350+ students nationally for a 8-10 week summer program at different US Universities…. Read More
The productivity of MIDD members during the last academic year was rewarded with several awards from the UWM Research Foundation. Patent awards were granted to Dr. Karyn Frick, Distinguished Professor, Neuroscience Area Chair, Neuroscience Major Director and CSO of co-founded… Read More
Function Therapeutics, a firm performing medicinal chemistry and pharmacology at UWM since June 2022, recently received a Phase 1 SBIR award from the National Science Foundation. The grant, Structure-guided design of anti-inflammatory modulators of protease-activated receptor 1 (PAR1), will support… Read More
We are happy to share that Avik Roy working as CSO at Simmaron Research received a NIH R21 grant in the amount of $450,000. The purpose of the grant is to study the role of autophagy-related protein ATG13 in the… Read More